Elanco Animal Health Inc (ELAN) shares plunged 7.56% in the pre-market session on Tuesday, as the company's financial guidance for the first quarter of 2025 and full-year 2025 fell short of Wall Street expectations.

For the first quarter of 2025, Elanco expects revenue in the range of $1.155 billion to $1.18 billion, missing the consensus estimate of $1.211 billion. The company also guided for adjusted earnings per share of $0.29 to $0.34, slightly below the expected $0.30 per share.

For the full year 2025, Elanco forecasts revenue between $4.445 billion and $4.51 billion, lower than the analysts' consensus of $4.533 billion. The company's adjusted earnings per share guidance of $0.80 to $0.86 also missed the expected $0.90.